Work

The promise of chimeric antigen receptor (CAR) T cell therapy in multiple myeloma

Year: 2019

Type: review

Source: Cellular Immunology

DOI: 10.1016/j.cellimm.2019.103964

Authors: Daniel Feinberg, Barry Paul, Yubin Kang

Institutions: Duke University, Duke Medical Center

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: green

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Cancer Institute, Duke Cancer Institute

Awards: G2729692343, G3891775111, G4588808251, G5841325822, G7553165789, Effects of PPAR agonists on response to immunomodulatory agents in patients with multiple myeloma, Clinical Trial of ABC294640 in Patients with Refractory Multiple Myeloma, Hematology & Transfusion Medicine

OpenAlex ID: W2967096120

FWCI: 0.453

Cites: 131

Cited by: 22

Related to: 10